Get started

Japan

$JPIRYY -Japan's Inflation Rate (CPI)ECONOMICS:JPIRYY 4% (January/2025) source: Ministry of Internal Affairs & Communications - The annual inflation rate in Japan climbed to 4.0% in January 2025 from 3.6% in the prior month, marking the highest reading since January 2023. Food prices rose at the steepest pace in 15 months (7.8% vs 6.4% in December), with fresh vegetables and fresh food contributing the most to the upturn. Further, electricity prices (18.0% vs 18.7%) and gas cost (6.8% vs 7.8%) remained elevated with the absence of energy subsidies since May 2024. Additional upward pressure also came from housing (0.8% vs 0.8%), clothing (2.8% vs 2.9%), transport (2.0% vs 1.1%), furniture and household items (3.4% vs 3.0%), healthcare (1.8% vs 1.7%), recreation (2.6% vs 4.0%), and miscellaneous items (1.4% vs 1.1%). In contrast, prices continued to fall for communication (-0.3% vs -2.1%) and education (-1.1% vs -1.0%). The core inflation rate rose to a 19-month high of 3.2%, up from 3.0% in December and topping consensus of 3.1%. Monthly, the CPI increased by 0.5%, after December's 14-month top of 0.6% rise.
ECONOMICS:JPIRYY
by Mr_J__fx
Why Morgan Stanley and MUFG back JPY? Morgan Stanley and MUFG both see the Japanese yen as the strongest G10 currency in 2025. They expect it to gain value as U.S. interest rates fall and Japan’s central bank raises its own. On the daily chart, USD/JPY oscillators are still away from being in the oversold zone, suggesting that the path of least resistance could to the downside. MUFG predicts further yen gains, especially against the euro, and has set a target of 150 for EUR/JPY, down from 157. Morgan Stanley also favors the Australian dollar. Meanwhile they believe the New Zealand dollar will appreciate but underperform the Australian dollar due to a weaker domestic outlook.
by BlackBull_Markets
$5020.T ENEOS HOLDINGS: REVENUE GROWTH, MAJOR IPO ENEOS HOLDINGS: REVENUE GROWTH, MAJOR IPO & DECARBONIZATION STRATEGY 1/8 Big News: Eneos Holdings ($5020.T) reported ¥14.97T revenue for FY 2024 (+9.8% YoY) thanks to higher oil prices & solid refining demand. They’ve also announced a massive JX Advanced Metals ($JXAM) IPO worth up to ¥460B—Japan’s largest in 7 years! 🏭💥 2/8 – EARNINGS SNAPSHOT • FY Net Income: ¥320.5B (↓12% YoY) due to rising costs & green investments 🌱⚡️ • Q3 Net Income: ¥85.4B (+3% QoQ) on cost optimization + refining margin boost • Dividend: ¥22/share—they’re not skimping on shareholder returns 💹💰 3/8 – SIGNIFICANT FINANCIAL EVENTS • JXAM IPO coming Mar 19, 2025—selling 50.1–58% stake • Could raise $2.6– SEED_TVCODER77_ETHBTCDATA:3B —funding Eneos’ decarbonization pivot & fueling shareholder value 🚀 • Market reacted positively (+1% in Eneos stock), while broader Japanese market stayed flat ⚖️ 4/8 – SECTOR COMPARISON • Valuation: P/E ~8.5 vs. global oil refiners (~10.2) & metals (~12.1) 🔎 • Revenue Growth: +9.8% outpacing Shell (6.2%) & ExxonMobil NYSE:XOM (7.8%), but below BHP (12.4%) • Undervalued? P/B ~0.9 vs. sector avg. 1.3, EV/EBITDA 6.8 vs. peers at 7.5. Looks attractive! 🔥 5/8 – RISK FACTORS • Oil Price Volatility: Refining margins can flip on a dime ⛽️💥 • Geopolitical Tensions: Japan relies heavily on energy imports 🌏 • Energy Transition Costs: ¥150B budget for renewables—major capex needed ♻️🔋 • JXAM IPO Execution: A poor market reception = potential stock hit ⚠️ 6/8 – REGULATORY & DECARBONIZATION • Japan targets net-zero by 2050—Eneos faces higher compliance costs 🌐 • Carbon capture & hydrogen investments: Could future-proof Eneos, but short-term margins may tighten 🤖⚡️ 7/8 – SWOT HIGHLIGHTS • Strengths: Diversified (refining + metals + renewables), top-tier Japanese refiner 🏆 • Weaknesses: Profit margin (2.1%) lags peers, heavy capex for transition 😬 • Opportunities: JXAM IPO frees capital; renewables & hydrogen for growth 🌱💡 • Threats: Shift away from fossil fuels, market skepticism 🚫⚡️ 8/8 Where do you see Eneos in 2025? 1️⃣ Bullish—Decarbonization + IPO = huge upside! 🐂 2️⃣ Cautiously Optimistic—Valuation looks good, but risks are real 🤔 3️⃣ Bearish—Oil refining can’t outrun global transitions 🐻 Vote below! 🗳️👇
TSE:5020Long
by DCAChampion
1
TradeCityPro | JASMYUSDT ATH in Market Cap👋 Welcome to the TradeCityPro channel! Let’s analyze one of Japan’s blockchain projects that allows users to control their data and earn income from IoT. 🌐 Overview Bitcoin Before starting the analysis, as always, let’s take a look at Bitcoin on the one-hour timeframe. It has practically gone to form a structure for itself, and we cannot trust the highs and lows it has created. Personally, I will stay away from futures for a while and focus on other tasks like checking DeFi projects and financial-related activities. Bitcoin dominance is currently fluctuating between a box of 61.05% to 61.87%. If it breaks above, the market's altcoins will drop further, and if it breaks below, Bitcoin itself will decline—but that seems unlikely. On the other hand, if Bitcoin dominance breaks above this range and the market remains bullish, Bitcoin itself will move more strongly. If the market remains bullish and Bitcoin dominance breaks below 61.05, more money will flow into altcoins, helping them recover and potentially start a new structure. 📊 Weekly Timeframe On the weekly timeframe, JASMY is one of the coins performing significantly better than other altcoins, trading at higher levels and not even on a major support despite the recent market correction. I’ve often talked about dormant money and buying after momentum entry in spot trading. If you look closely, for 500 days, we were inside a box between 0.00308 and 0.00715—similar to most altcoins. However, the key point is that the last rejection from the top of the range didn’t return to the bottom; instead, we registered a higher low compared to the range’s bottom. This increases the probability of breaking above the range. After breaking the range, we took a buy position with a stop-loss at the higher low (0.00494) and achieved around 600% profit up to the formed high. I personally do not intend to exit yet and will stay in the trade as long as we are above 0.01672. For re-entry, either we need to see a good reaction to the 0.01672 support, wait for a breakout of 0.03878, or wait for consolidation and a better structure on lower timeframes. I personally prefer not to buy when the market is in a range without momentum. If we draw a Fibonacci retracement from the previous low to the current high, the 0.01672 level (which is the 0.382 Fibonacci level) is a very important zone. If we bounce from this area and break the 0.03878 resistance (I consider any movement above this level before a confirmation as a fake-out), we can expect a strong uptrend, targeting 0.06413, 0.09197, and 0.14558. 📈 Daily Timeframe On the daily timeframe, we are still above our main support at 0.01636. This support is so important that if we intend to start another primary trend, we should not drop below it; otherwise, our mid-wave cycle (MWC) will become bearish. I also wanted to mention the difference between market cap and price. Right now, in 2025, even though the price is lower than its previous ATH of 0.05940, more money is in this coin, meaning it has a higher market cap. A new all-time high has been formed in its market cap. Why? Because inflation and more token distribution have resulted in a higher market cap despite a lower price, meaning the token has lost value. We also have a very strong trendline on this timeframe. The last rejection from this trendline has made it even more significant. After its breakout, we can enter a risky buy without a trigger, or wait for the breakout of 0.03979, which is a very strong trigger for momentum and spot buying. 📝 Final Thoughts Stay calm, trade wisely, and let's capture the market's best opportunities! This analysis reflects our opinions and is not financial advice. Share your thoughts in the comments, and don’t forget to share this analysis with your friends! ❤️
Long
by tradecitypro
10
Japan Aesthetics Market Set for Rapid Growth The Japan aesthetics market is on a trajectory of significant expansion, with a projected rise from $4.15 billion in 2025 to $12.97 billion by 2034, driven by a CAGR of 13.50%. This growth is fueled by an aging population, rising demand for non-invasive cosmetic treatments, and increasing consumer interest in aesthetic enhancements. Industry leaders such as Jiyugaoka Clinic, Big Blue株式会社, and Nasdaq-listed SBC Medical are poised to benefit from this flourishing market. Surging Demand for Non-Invasive Aesthetic Treatments One of the most significant trends propelling the Japan aesthetics market is the increasing preference for non-invasive and minimally invasive procedures. Treatments like Botox, dermal fillers, laser therapy, and chemical peels are gaining popularity due to their ability to deliver natural-looking results with minimal downtime. This shift in consumer behaviour, particularly among millennials and middle-aged individuals, is pushing clinics and medical institutions to expand their service offerings. Among the key players, Jiyugaoka Clinic is at the forefront of providing advanced non-surgical aesthetic solutions, leveraging cutting-edge technology to meet the growing demand. Similarly, Big Blue株式会社, a prominent player in Japan’s medical aesthetics industry, is expected to capitalise on the rise of minimally invasive procedures by integrating the latest technology into its service offerings. Aging Population Driving Growth in Anti-Aging Aesthetics Japan’s rapidly aging population is another key driver of market growth. As more individuals seek anti-aging solutions to maintain a youthful appearance and boost self-esteem, the demand for procedures targeting wrinkles, skin laxity, and facial volume loss is accelerating. SBC Medical, a Nasdaq-listed company, is well-positioned to cater to this demand, with a strong presence in Japan’s aesthetic industry and a portfolio of innovative anti-aging treatments. The rising disposable income among Japan’s older demographic is further amplifying demand, leading to increased investment in cosmeceuticals, skin rejuvenation procedures, and cosmetic implants. The trend toward maintaining a youthful look is fostering continuous advancements in facial aesthetics and body contouring solutions, ensuring sustained market growth. Technological Innovations Fueling Market Expansion The aesthetics market in Japan is evolving rapidly due to the integration of state-of-the-art technology in aesthetic treatments. The country’s emphasis on precision, safety, and innovation has led to the development of AI-assisted skin analysis, laser resurfacing, and next-generation cosmetic implants. Jiyugaoka Clinic and Big Blue株式会社 are actively incorporating these advancements, providing highly personalised and effective treatment options to cater to diverse consumer needs. Moreover, SBC Medical’s presence on the Nasdaq market enhances its ability to attract global investors and leverage international expertise in aesthetic dermatology and plastic surgery. With access to cutting-edge research and development, the company is expected to introduce groundbreaking treatments that further strengthen Japan’s position as a leader in the aesthetics industry. A Booming Market with Expanding Opportunities The Japan aesthetics market is poised for exponential growth, driven by increasing awareness, changing beauty standards, and evolving medical advancements. The rise of non-invasive procedures, combined with a strong demand for anti-aging treatments, is creating a lucrative environment for Jiyugaoka Clinic, Big Blue株式会社, and SBC Medical to thrive. As consumer preferences shift towards customised, technology-driven aesthetic solutions, these industry leaders are well-equipped to meet demand, ensuring sustained market dominance in the years to come. Investors and industry stakeholders should closely watch Japan’s aesthetics market, as it continues to set new benchmarks for innovation, safety, and personalised beauty treatments.
NASDAQ:SBCLong
by HASHInvests200
$JPINTR -Japan's Interest Rate (December/2024)ECONOMICS:JPINTR 3.6% (December/2024) source: Ministry of Internal Affairs & Communications - The annual inflation rate in Japan jumped to 3.6% in December 2024 from 2.9% in the prior month, marking the highest reading since January 2023. Food prices rose at the steepest pace in a year (6.4% vs 4.8% in November), with fresh vegetables and fresh food contributing the most to the upturn. Further, electricity prices (18.7% vs 9.9%) and gas cost (5.6% vs 3.5%) increased at the fastest rate in four months with the absence of energy subsidies since May. Additional upward pressure also came from housing (0.8% vs 0.9%), clothing (2.9% vs 2.6%), transport (1.1% vs 0.9%), furniture and household utensils (3.0% vs 3.7%), healthcare (1.7% vs 1.6%), recreation (4.0% vs 4.5%), and miscellaneous items (1.1% vs 1.1%). In contrast, prices continued to fall for communication (-2.1% vs -3.0%) and education (-1.0% vs -1.0%). The core inflation rate rose to a 16-month high of 3.0%, up from 2.7% in November and matching consensus. Monthly, the CPI increased by 0.6%, the highest figure in 14 months.
ECONOMICS:JPINTR
by Mr_J__fx
jasmy (JASMY) - lines from before nowI logged in to see the coverage of lines I drew awhile ago. Looks like the price of jasmy is close to one of those lines. I wonder if the price will rebound. Not much else to say. My inclination to believe the price of jasmy would sustain itself was not aligned well with the amount of seduction people found from selling. typical scenarios of investment. I am really trying hard to find an investment that does not lose like this but I remain confident in Jasmy.
COINBASE:JASMYUSD
by CryptocurrencyBlot
3
Japanese inflation and BoJ rate decision coming upLet's have a look what may happen with MARKETSCOM:JAPAN225 and FX_IDC:USDJPY after we get the Japanese data on Friday. We will be monitoring the data carefully, especially the rate decision, as it will be the first hike since July of last year. 74.2% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Past performance is not necessarily indicative of future results. The value of investments may fall as well as rise and the investor may not get back the amount initially invested. This content is not intended for nor applicable to residents of the UK. Cryptocurrency CFDs and spread bets are restricted in the UK for all retail clients.
by Marketscom
My 2 cents on the technical movement of this stock..The recent price action of SBC Medical Group Holdings indicates consolidation within the $5.00 to $6.00 range, with $5.00 acting as a strong support level and $6.00 as immediate resistance. The stabilisation at these levels reflects reduced volatility, hinting at a potential accumulation phase. Volume spikes near the $5.00 level further suggest that institutional investors may be positioning themselves, adding to the likelihood of accumulation. This price behaviour indicates a cautious yet potentially promising setup for a breakout. Given the current context, a decisive move above $6.00 with increasing volume would confirm a shift in momentum, opening the possibility for a sustained upward trajectory. Conversely, failure to maintain the $5.00 support could lead to further testing of lower levels, making this range a crucial area to watch. The overall stability around these levels suggests growing interest and positioning ahead of a possible directional move.
NASDAQ:SBCLong
by dibora_yen91
1
BUY Rating: SBC Medical Group – A Compelling Growth StorySBC Medical Group Holdings (NASDAQ: SBC), a leader in end-to-end solutions for aesthetic clinics, has earned a "BUY" rating, reflecting its robust growth trajectory and strategic expansion initiatives. The company’s recent performance and forward-looking plans justify its valuation, presenting an attractive opportunity for investors. Valuation and Market Position Compared with SBC’s current price with a valuation target of $11, underscores its growth potential. Despite facing challenges like fluctuating exchange rates and integration costs from recent acquisitions, the company’s fundamentals remain strong. SBC’s market capitalisation stands at $697 million, supported by an annual revenue estimate of $217 million for 2024, reflecting a year-over-year growth of 12%. While SBC operates in the competitive medical aesthetics space, its comprehensive suite of consulting, marketing, and equipment leasing services distinguishes it from peers. The company’s ability to generate steady revenue and expand profit margins highlights its efficiency in leveraging its unique business model. International Expansion Driving Growth A pivotal driver of SBC's growth is its strategic acquisition of Aesthetic Healthcare Holdings (AHH) in Singapore. AHH operates 21 outlets under established brands like SkinGo! and The Chelsea Clinics. Singapore's business-friendly regulatory environment, strong economic growth, and status as a regional hub make it an ideal base for SBC’s expansion into Southeast Asia. Singapore’s GDP growth and high levels of U.S. foreign direct investment further validate SBC’s choice to focus on the region. This acquisition not only accelerates SBC's regional footprint but also positions the company to capitalise on the growing demand for aesthetic services across Asia. Financial Highlights SBC’s Q3 2024 revenue reached $53.1 million, a 12.3% year-over-year increase, with gross profit rising to $43.2 million and margins improving to 81.5% from 70.9% in the prior year. This growth was driven by a shift toward higher-margin revenue streams, including royalty income (29.6% of revenue) and procurement services (33.1%). The company’s decision to discontinue its lower-margin management services business has further enhanced its profitability. Net income for the quarter was $2.8 million, or $0.03 per share, with strong contributions from franchisee expansion and increased demand for aesthetic treatments. Financial Flexibility SBC's financial position is robust, with $137.4 million in cash and equivalents and less than $15 million in long-term debt as of Q3 2024. This financial flexibility enables the company to fund its growth strategies, including further acquisitions and geographic expansion. Strategic Initiatives Beyond its international expansion, SBC has entered partnerships to enhance customer loyalty and corporate wellness offerings. Its alliance with MEDIROM Healthcare in Japan integrates the loyalty programs of both companies, providing access to over 4 million members. SBC also launched SBC Wellness to offer corporate clients improved employee benefits, tapping into the growing demand for wellness services. Growth Catalysts The rising global acceptance of aesthetic medicine, coupled with SBC’s established expertise in high-demand procedures such as liposuction, breast augmentation, and eyelid surgery, positions the company for continued growth. With low market penetration for these services in Japan (estimated at 10%), there is significant upside as demand grows among younger and middle-aged demographics. Risks and Outlook While SBC faces risks such as foreign exchange fluctuations and potential challenges in integrating new acquisitions, its strong balance sheet and strategic focus mitigate these concerns. As the company continues to execute its growth initiatives, share price appreciation and valuation multiple expansion are likely. Conclusion SBC Medical Group Holdings presents a compelling investment opportunity, with a clear path to growth through strategic international expansion, enhanced profitability, and innovative partnerships. Its current valuation offers an attractive entry point for investors seeking exposure to the growing medical aesthetics sector. With strong financials and a proven business model, SBC is well-positioned to deliver long-term shareholder value.
NASDAQ:SBCLong
by HASHInvests200
$JPINTR - Japan's Interest RateECONOMICS:JPINTR (Devember/2024) source: Bank of Japan -The Bank of Japan (BoJ) maintained its key short-term interest rate at around 0.25% during its final meeting of the year, keeping it at the highest level since 2008 and meeting market consensus. The vote was split 8-1, with board member Naoki Tamura advocating for a 25bps increase. Thursday's decision came despite the US implementing its third rate cut this year, as the BoJ needed more time to assess certain risks, particularly US economic policies under Donald Trump and next year's wage outlook. The board adhered to its assessment that Japan's economy is on track for a moderate recovery, despite some areas of weakness. Private consumption continued its upward trend, aided by improving corporate profits and business spending. Meanwhile, exports and industrial output remained relatively flat. On inflation, the YoY figures have ranged between 2.0% and 2.5%, driven by higher service prices. Inflation expectations showed a moderate rise, and the underlying CPI is expected to add gradually.
ECONOMICS:JPINTR
by Mr_J__fx
JAPAN 225 INDEX Bullish Projection CHART Technical Analysis of Japan 225 Index (4H Chart) Overview: The Japan 225 index, as depicted on the 4-hour chart, is currently navigating through a complex pattern with multiple trend lines and Fibonacci retracement levels in play. RSI signaling bullish technically, within zone of "overvalued." This is in alignment with both Trends and Horizontal Support along with multiple other indicators. Also to note, it is falling towards the 200 EMA, it is about to close a gap on a pattern that has broken out bullish, which aligns with a major trend and horizontal support area, which then takes us to the next trendline, which is a bearish trend trading in a bullish direction. Essentially, this is a really important zone. Price either breaks downward, and likely closes another gap showing in yellow on the chart OR price hits support and we really start to see an upward climb. This movement would be similar to how the SP500 is melting up towards the 6500 range. Here's a detailed analysis: Trend Analysis: Support Trend Line: The price is holding above a key ascending support trend line, which has been in place for several months. This trend line acts as a bullish indicator, suggesting that the index has been in an uptrend. Descending Resistance Line: There is a descending resistance trend line that the price is approaching. A breakout above this line could signal a continuation of the uptrend and potentially lead to higher targets. Fibonacci Retracement Levels: 38.2% Retracement: The price is currently testing this level around 39,015.11. This is a common retracement level where price often finds support or resistance. 50% Retracement: Located at 38,015.11, this level could act as a strong support if the price breaks below the 38.2% level. 61.8% Retracement: Around 37,015.11, this is a critical level where a deeper pullback might find support before a potential reversal. Volume Analysis: Volume Indicators: There is a noticeable increase in volume at key support and resistance levels, indicating strong buying or selling interest. The recent volume spike suggests significant market activity, which could precede a major move. MACD (Moving Average Convergence Divergence): MACD Line and Signal Line: The MACD line is above the signal line, which is typically a bullish sign. However, the histogram shows decreasing momentum, which might indicate a potential slowdown or reversal in the current trend. Price Targets: Upside Targets: If the price breaks above the descending resistance trend line, the next resistance levels to watch are around 39,015.11 (38.2% Fibonacci), followed by 40,015.11 and 41,015.11. Downside Targets: A break below the ascending support trend line could see the price retesting the 50% and 61.8% Fibonacci levels, around 38,015.11 and 37,015.11, respectively. Conclusion: The Japan 225 index is at a critical juncture, with multiple technical indicators suggesting both potential continuation of the uptrend and possible consolidation or pullback. Traders should watch for a breakout above the descending resistance or a breakdown below the ascending support for clearer directional cues. Monitoring volume and MACD for confirmation of these moves will be crucial for making informed trading decisions.
TVC:NI225Long
by nicktussing77
jasmy (JASMY) "INDICATIONS"The BBTrend indicator reveals whether the price is overbought or oversold. Red is too low "oversold" and green is too high "overbought." In this case Jasmy is quite neutral on that fact. The Yellow stepped line is the 100 Moving Average. When the 100 MA is smoothing out and rounding over this is a sign of the price reversing. As you can see the steps are large and there is no smoothing happening. Also with my 2x100 indicator the waves run between the two lines like a MACD with the 100MA line on top for positive growth and when the smooth green line crosses over the stepped line this is a sign of a reversal as well. As you can see the recent price increase is therefore sturdy based on these two indications.
COINBASE:JASMYUSD
by CryptocurrencyBlot
1
USD/JPY:Yen Recovers as Interventions and Geopolitical Tensions The Japanese Yen has gained some ground against the U.S. Dollar, leading the USD/JPY pair to settle at 154.30 on Friday. This recovery is fueled by speculation that Japanese authorities may intervene in the foreign exchange market to support the domestic currency. Additionally, rising geopolitical tensions are providing further backing for the safe-haven JPY. Though the Yen is finding support, a slight decline in the U.S. Dollar is also helping to limit the upward movement of the currency pair. As noted in our previous discussion, the Dollar Index (DXY) appeared poised for a retracement. However, at the time of writing, the USD has managed to regain some strength against the JPY, trading around 154.72. Analysis from the Commitment of Traders (COT) report suggests a potential reversal in the market's direction. Furthermore, historical seasonality trends indicate a possible shift toward bearish conditions, reflecting patterns observed over the last decade. This raises the possibility of continued bearish momentum for the USD/JPY pair moving forward. ✅ Please share your thoughts about USD/JPY in the comments section below and HIT LIKE if you appreciate my analysis. Don't forget to FOLLOW ME; you will help us a lot with this small contribution.
Short
by FOREXN1
1